Company Filing History:
1 out of 344 
1 out of 102 Years Active: 2015
Title: The Innovative Contributions of Janet Ozer
Introduction: Janet Ozer is a notable inventor based in Ashdod, Israel, recognized for her significant contributions to the field of therapeutics. With a unique approach to inhibiting the nuclear factor kappa B (NF-κB) pathway, she has made strides in developing methods that have the potential to treat various diseases, including cancer and viral infections.
Latest Patents: Janet Ozer holds one patent titled "Methods and compositions for inhibiting the nuclear factor kappa B pathway." This invention focuses on therapeutic methods that harness an active fraction of a plant extract known as NUP. The discovery of this fraction has paved the way for new strategies in managing diseases characterized by inflammation and infections.
Career Highlights: Throughout her career, Janet has worked with esteemed organizations such as the Ben-Gurion University of the Negev Research and Development Authority and Mor Research Applications Ltd. Her work in these institutions has enabled her to collaborate with leading scientists and researchers, further enhancing her innovative capabilities.
Collaborations: Janet has had the opportunity to collaborate with colleagues such as Avi Golan and Jacob Gopas. Together, they have worked on developing research projects that advance the understanding and application of her patented methods.
Conclusion: Janet Ozer exemplifies the spirit of innovation in the world of science and therapeutics. With her patented techniques aimed at inhibiting the NF-κB pathway, she is contributing to the ongoing fight against significant health challenges. Her work not only reflects her dedication to research and development but also highlights the critical role of inventors in the advancement of medical science.